News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
138 Results
Type
Article (26)
Press Release (112)
Section
Business (21)
Deals (13)
Drug Development (19)
FDA (6)
Job Trends (3)
News (45)
Policy (2)
Tag
Academia (2)
Alliances (3)
Approvals (6)
Best Places to Work (2)
Cancer (1)
CAR-T (2)
Cell therapy (3)
Clinical research (9)
C-suite (1)
Data (8)
Diabetes (8)
Earnings (13)
Events (29)
FDA (7)
Gene therapy (7)
GLP-1 (18)
Healthcare (22)
IPO (14)
Layoffs (2)
Medical device (4)
Medtech (4)
Metabolic disorders (19)
NextGen: Class of 2025 (1)
Obesity (10)
Pancreatic cancer (1)
Patents (1)
People (10)
Phase I (5)
Phase II (5)
Phase III (5)
Pipeline (4)
Postmarket research (2)
Preclinical (7)
Regulatory (2)
Research institute (1)
Startups (3)
The Weekly (1)
Weight loss (6)
Date
Last 30 days (1)
Last 365 days (32)
2025 (26)
2024 (45)
2023 (18)
2022 (9)
2021 (11)
2020 (5)
2019 (5)
2018 (1)
2017 (6)
2016 (5)
2015 (5)
2014 (2)
Location
Asia (2)
California (1)
Europe (5)
Massachusetts (36)
Ohio (1)
Southern California (1)
United States (38)
138 Results for "fractyl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
September 29, 2025
·
7 min read
Press Releases
Fractyl Health Announces Proposed Public Offering
August 6, 2025
·
7 min read
Press Releases
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity
October 8, 2025
·
9 min read
Press Releases
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
August 13, 2025
·
17 min read
Press Releases
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
September 29, 2025
·
9 min read
Layoffs
Fractyl Goes All In on GLP-1 Off-Ramp Drug, Lays of 17% of Workforce
Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and parting with around 22 employees in an attempt to extend its runway into 2026.
January 31, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
August 7, 2025
·
1 min read
Press Releases
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
August 8, 2025
·
3 min read
Press Releases
Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
May 14, 2025
·
12 min read
Press Releases
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
June 19, 2025
·
7 min read
1 of 14
Next
